About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in California | 1,207 Studies

Clinical Trials Prostate CancerCalifornia

Prostate Cancer Clinical Trials in California

Find 1,207 clinical trials for prostate cancer near California. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 721-740 of 1,207 trials

RecruitingStudy of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate CancThis is an open-label, multi-site study of AR Blockade with carotuximab in patients who have progressed on androgen receptor signaling inhibitor (ARSI) therapy.NCT05534646·Duarte, California and 2 others CompletedIntra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate CancerThis pilot clinical trial studies the best dose of anti-prostate specific membrane antigen (PSMA) monoclonal antibody MDX1201-A488 (MDX1201-A488) given before surgery to aid in…NCT02048150·Duarte, California CompletedSildenafil in Treating Erectile Dysfunction in Patients With Prostate CancerRATIONALE: Sildenafil may be effective in helping patients who have undergone treatment for prostate cancer to have an erection for sexual activity and may improve sexual…NCT00057759·Concord, California and 29 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate CancerThis is a phase 1 study to assess the safety and tolerability of ARX517 as monotherapy or combination therapy in adult subjects with metastatic prostate cancer (mPC).NCT04662580·La Jolla, California and 11 others

TerminatedStudy of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate CancerThis study is for patients who have been treated with surgical removal of the testes or hormone therapy (Lupron or Zoladex) and whose prostate cancer has worsened despite this…NCT00183937·Los Angeles, California

CompletedGallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After SurgeryThis phase II trial compares how well gallium 68-labeled PSMA-11 positron emission tomography/computed tomography (PET/CT) works compared to fluciclovine F18 PET/CT in imaging…NCT03515577·Los Angeles, California

CompletedStudy With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate CancerThis single arm, multicenter, open-label, Phase II study will enroll chemotherapy-naive participants with metastatic, histologically-confirmed adenocarcinoma of the prostate…NCT00520481·San Francisco, California and 2 others

CompletedCarboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate CancerThe goal of this clinical research study is to learn about how effective 2 chemotherapy drugs carboplatin (Paraplatin) plus docetaxel (Taxotere) in the treatment of patients with…NCT00514540·San Francisco, California and 1 other

Active not recruitingA Study of ARV-766 Given by Mouth in Men With Metastatic Prostate CancerThis first-in-human, Phase 1/2, open-label study evaluates the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of JSB462 (luxdegalutamide, previously…NCT05067140·Duarte, California and 16 others

Active not recruitingSaruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal AgentsThe intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician's choice NHA relative to placebo + physician's choice NHA by assessment of radiographic…NCT06120491·Chandler, Arizona and 321 others

Not yet recruitingFolate Study in Men With Advanced Prostate CancerThe researchers hope to learn if Trimethoprim, 150mg taken daily for 3 months, is a safe and effective way to reduce folate levels at time of Androgen Deprivation Therapy (ADT) in…NCT06536374·La Jolla, California

RecruitingStudy of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) MutationThis is an open-label, multi-center, phase 1b study designed to determine a tolerable dose of CX-5461 administered by IV infusion on Day 1 and Day 8 of a 28-day cycle in patients…NCT04890613·Santa Monica, California and 7 others

CompletedEvaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing ProstatectomyIn this phase II study, an investigative (not approved by the FDA) drug called GPI 1485 is being assessed to see if it can help preserve erectile function after prostatectomy.NCT00090376·Phoenix, Arizona and 24 others

CompletedStudy of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)The purpose of this study is to evaluate the efficacy and safety of olaparib versus enzalutamide or abiraterone acetate in subjects with metastatic castration-resistant prostate…NCT02987543·Anchorage, Alaska and 203 others

CompletedA Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate CancerComparing the effect of switching from Lupron and Zoladex to Eligard.NCT00220194·San Bernardino, California

RecruitingA Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate CancerThe primary objective of this study is to compare overall survival (OS) in participants receiving xaluritamig plus abiraterone against investigator's choice (docetaxel…NCT07213674·Goodyear, Arizona and 155 others

TerminatedAn Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesThis was a study of INCB054329 given to patients with advanced malignancies that were conducted in three treatment groups.NCT02431260·Los Angeles, California and 11 others

RecruitingTwo-fraction HDR Monotherapy for Localized Prostate CancerThis is a single center single arm prospective pilot study investigating the safety of high dose rate (HDR) brachytherapy as monotherapy delivered in 2 fractions 3 hours apart.NCT05665738·San Francisco, California

TerminatedA Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate CarcinomaThis is a phase 1, open-label study evaluating the safety, clinical pharmacology and clinical activity of AMG 340, a PSMA x CD3 T-cell engaging bispecific antibody, in subjects…NCT04740034·San Francisco, California and 6 others

RecruitingVascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray TreatmentWith people living longer after being treated for prostate cancer, quality of life has become a concern when considering the treatment plan.NCT07293585·Los Angeles, California

PreviousPage 37 of 61Next

Other Conditions in California

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma